Dishman Carbogen Amcis Limited
Dishman Carbogen Amcis Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: DCAL and BSE: 540701 (ISIN INE385W01011).
It has a market capitalisation of ₹2,286 crore, a last close of ₹145.80 on 2026-10-19, a one-year return of -47.6%.
Valuation: a price-to-earnings ratio of 141x, a price-to-book ratio of 0.34x, a dividend yield of 0.0%.
Profitability: return on equity of 1.6%, return on capital employed of 3.2%, an operating margin of 16.7%.
Growth: sales growth of 6.7% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.42x, promoter holding of 59.3%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,286 |
| Last close | ₹145.80 |
| P/E (TTM) | 141x |
| P/B | 0.34x |
| Dividend yield | 0.0% |
| ROE (FY) | 1.6% |
| ROCE (FY) | 3.2% |
| Operating margin (TTM) | 16.7% |
| Sales growth, 3-year CAGR | 6.7% |
| Debt / equity | 0.42x |
| Promoter holding | 59.3% |
| 1-year return | -47.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means